STOCK TITAN

ESCO Technologies FY2026 net sales rise 21% to $1.32B

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

ESCO Technologies Inc. (ESE) reported fiscal 2026 net sales of $1,322.021 million, up 21% from $1,095.388 million. Diluted GAAP EPS from continuing operations was $5.63, up 25% from $4.49; non-GAAP adjusted EPS from continuing operations was $8.42, up 40% from $6.03. Entered orders rose 11% to $1,737.2 million, and backlog was $1,548.816 million at September 30, 2026.

Fourth-quarter net sales were $383.994 million, up 9% from $352.674 million. Diluted GAAP EPS from continuing operations was $1.97, up 14% from $1.73, and adjusted EPS was $2.67, up 15% from $2.32. Fourth-quarter entered orders rose 22% to $392.295 million. Fiscal 2026 operating cash flow from continuing operations was $295.595 million, versus $200.396 million in fiscal 2025.

At September 30, 2026, long-term debt was $14.0 million, compared with $166.0 million at September 30, 2025. The next $0.08-per-share quarterly cash dividend is payable January 19, 2027, to stockholders of record January 4, 2027.

4 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 0 points

How the balance works

Positive

  • Moderate pointFY 2026 net sales rose 21% to $1,322.021 million.
  • Moderate pointFY 2026 GAAP EPS from continuing operations rose 25% to $5.63.
  • Moderate pointFY 2026 adjusted EPS from continuing operations rose 40% to $8.42.
  • Moderate pointFY 2026 continuing-operations operating cash flow rose to $295.595 million, from $200.396 million.

Negative

  • None.

Filing Explained

The PSU share outcome remains undetermined until the performance period ends and the committee certifies results.

The committee approved fiscal 2027 equity awards for three executive officers on November 16, 2026; they have not vested, and shares delivered upon vesting would increase the share count and reduce existing holders’ percentage ownership.

The RSU grants were 5,083 for Bryan Sayler, 1,452 for Christopher Tucker and 884 for David Schatz; their PSU target payouts are 11,861, 3,389 and 2,063 shares, respectively, with maximums of 23,722, 6,778 and 4,126.

RSUs vest in three equal portions on the last NYSE trading days in November 2027, 2028 and 2029. The PSU performance period runs from October 1, 2026 through September 30, 2029, with payout after committee certification; goals weight EBITDA at 60% and return on invested capital at 40%, and below-threshold performance means no payout for that portion. Relative TSR can reduce the resulting PSU shares by 20% below the 25th percentile or increase them by 20% above the 75th percentile; results between those points receive no adjustment.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
FY 2026 net sales $1,322.021 million Fiscal year ended September 30, 2026; up 21% from $1,095.388 million in fiscal 2025.
FY 2026 diluted GAAP EPS from continuing operations $5.63 per share Fiscal year ended September 30, 2026; up 25% from $4.49 in fiscal 2025.
FY 2026 adjusted EPS from continuing operations $8.42 per share Fiscal year ended September 30, 2026; up 40% from $6.03 in fiscal 2025.
FY 2026 entered orders $1,737.2 million Fiscal 2026; up 11% from fiscal 2025.
Q4 2026 net sales $383.994 million Three months ended September 30, 2026; up 9% from $352.674 million in Q4 2025.
Q4 2026 diluted GAAP EPS from continuing operations $1.97 per share Three months ended September 30, 2026; up 14% from $1.73 in Q4 2025.
Q4 2026 adjusted EPS from continuing operations $2.67 per share Three months ended September 30, 2026; up 15% from $2.32 in Q4 2025.
Q4 2026 entered orders $392.295 million Fourth quarter of fiscal 2026; up 22% from Q4 2025.
Restricted Share Units (RSUs) technical
"time-based Restricted Share Units (RSUs) and Performance Share Units (PSUs)"
Restricted share units (RSUs) are a form of employee pay where a company promises to give shares (or their cash value) to workers after certain conditions, usually time or performance, are met. For investors, RSUs matter because they can increase the number of shares outstanding and signal how management is being paid and incentivized—think of them as delayed bonuses that convert into ownership when vesting conditions are satisfied.
Performance Share Units (PSUs) technical
"time-based Restricted Share Units (RSUs) and Performance Share Units (PSUs)"
EBITDA financial
"performance goals for the fiscal 2027 PSUs are specified Committee-approved targets for EBITDA (60%)"
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It measures a company's profitability by focusing on the money it makes from its core operations, ignoring expenses like taxes and accounting adjustments. Investors use EBITDA to compare how well different companies are performing financially, as it provides a clearer picture of operational success without the influence of financial structure or accounting choices.
Return on Invested Capital financial
"EBITDA (60%) and Return on Invested Capital (40%)"
A percentage that shows how effectively a company turns the money invested in its business—both borrowed funds and shareholders’ equity—into operating profit after taxes. It tells investors whether a company earns more from its core operations than it costs to fund those operations; think of it like the annual return you’d expect from renovating a rental property—higher percentages mean the company uses capital more efficiently and is more likely to create value for shareholders.
rTSR financial
"compared to the TSR of the companies in a peer group based on the S&P Small-Cap 600 Industrials Index (rTSR)"
Adjusted EPS financial
"Q4 Adjusted EPS from continuing operations"
Adjusted earnings per share (adjusted eps) is a measure of a company's profit per share that has been modified to exclude certain one-time or unusual items, such as costs from restructuring or asset sales. It provides a clearer picture of the company’s core performance by removing events that may distort the usual earnings. Investors use adjusted eps to better understand a company's ongoing profitability and compare it more accurately over time.
Q4 net sales $383.994 million Up 9% from $352.674 million in Q4 2025.
Q4 entered orders $392.295 million Up 22%.
Q4 diluted GAAP EPS from continuing operations $1.97 per share Up 14% from $1.73 in Q4 2025.
Q4 adjusted EPS from continuing operations $2.67 per share Up 15% from $2.32 in Q4 2025.
FY 2026 net sales $1,322.021 million Up 21% from $1,095.388 million in FY 2025.
FY 2026 entered orders $1,737.2 million Up 11%.
FY 2026 diluted GAAP EPS from continuing operations $5.63 per share Up 25% from $4.49 in FY 2025.
FY 2026 adjusted EPS from continuing operations $8.42 per share Up 40% from $6.03 in FY 2025.
Guidance

The business outlook refers to expectations for growth in FY 2027 compared with FY 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did ESE report for fiscal 2026?

Fiscal 2026 net sales were $1,322.021 million, up 21% from $1,095.388 million. Diluted GAAP EPS from continuing operations was $5.63, up 25% from $4.49; non-GAAP adjusted EPS from continuing operations was $8.42, up 40% from $6.03.

How did ESE perform in the fourth quarter of 2026?

Fourth-quarter net sales were $383.994 million, up 9% from $352.674 million. Diluted GAAP EPS from continuing operations was $1.97, up 14% from $1.73, while adjusted EPS was $2.67, up 15% from $2.32. Entered orders were $392.295 million, up 22%.

What were ESE's fiscal 2026 entered orders and year-end backlog?

Fiscal 2026 entered orders were $1,737.2 million, up 11%. Backlog was $1,548.816 million at September 30, 2026.

When will ESE pay its next quarterly dividend?

The next quarterly cash dividend is $0.08 per share, payable January 19, 2027, to stockholders of record January 4, 2027.

How does relative TSR affect ESE's fiscal 2027 PSU payout?

The resulting share count is decreased 20% below the 25th percentile or increased 20% above the 75th percentile. From the 25th percentile to the 75th percentile, no adjustment is made.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0000866706 0000866706 2026-11-16 2026-11-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION 

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): November 16, 2026

 

ESCO TECHNOLOGIES INC.

 (Exact Name of Registrant as Specified in Charter)

 

Missouri 1-10596 43-1554045
(State or Other (Commission (I.R.S. Employer
Jurisdiction of Incorporation) File Number) Identification No.)

 

645 Maryville Centre Drive, Suite 300, St. Louis, Missouri 63141-5855
(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s telephone number, including area code: 314-213-7200

 

Securities registered pursuant to section 12(b) of the Act:

 

        Name of each exchange
Title of each class   Trading Symbol(s)   on which registered
Common Stock, par value $0.01 per share   ESE   New York Stock Exchange

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨   Pre-commencement communications pursuant to Rule 14d-2 (b) under the Exchange Act (17 CFR 240.14d-2 (b))

 

¨   Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.113d-4 (c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).       Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

  

 

 

 

Item 2.02Results of Operations and Financial Condition

 

Today, November 19, 2026, ESCO Technologies Inc. (the Registrant, or the “Company”) is issuing a press release (furnished as Exhibit 99.1 to this report) announcing its financial and operating results for the fourth quarter and fiscal year ended September 30, 2026. See Item 7.01, Regulation FD Disclosure, below.

 

Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

Executive Officers – Long-Term Equity Incentive Awards

 

On November 16, 2026, the Human Resources and Compensation Committee of the Company’s Board of Directors approved the fiscal 2027 awards of time-based Restricted Share Units (RSUs) and Performance Share Units (PSUs) to the Company’s three executive officers and the other participants in the Company’s LTI program, effective November 16, 2025.

 

Other than the share amounts, the terms of the fiscal 2027 RSUs are substantially similar to those awarded for fiscal 2026, vesting in three equal portions on the last NYSE trading days in November 2027, 2028 and 2029.

 

The terms of the fiscal 2027 PSUs are substantially similar to those awarded for fiscal 2026 other than the specific share amounts and performance goals. The fiscal 2027 PSUs will vest after a three-year performance period beginning October 1, 2026 and ending on September 30, 2029, on the last trading day of the month in which the HRCC approves and certifies the extent to which the applicable performance goals have been achieved. Upon vesting, the awards will be converted into a currently undeterminable number of shares of Company common stock, which may be less than or greater than the number of PSUs awarded, within certain specified threshold and maximum limits, depending on the degree to which the Company has achieved one or more specified performance goals. If the performance is less than the threshold goal for a particular performance measure, there will be no payout of that portion of the PSUs dependent on that measure.

 

The performance goals for the fiscal 2027 PSUs are specified Committee-approved targets for EBITDA (60%) and Return on Invested Capital (40%), with the resulting number of shares potentially subject to increase or decrease based on the Company’s Total Shareholder Return (TSR) over the performance period compared to the TSR of the companies in a peer group based on the S&P Small-Cap 600 Industrials Index (rTSR). If the Company’s rTSR is below the 25th percentile or above the 75th percentile, the resulting number of shares will be decreased by 20% or increased by 20%, respectively; if the Company’s rTSR is from the 25th percentile to the 75th percentile, no adjustment will be made.

 

The target number of shares in each RSU and PSU award equals the Committee-approved target values divided by the 15-day average trading price of the Company’s stock. The actual payout of the RSUs and PSUs will be in shares, whose value at the time of payout may be greater or less than the target values.

 

 

 

 

For the executive officers, the numbers of RSUs granted and the PSU threshold, target and maximum numbers of shares payable according to the performance criteria, were as follows:

 

                      PSU Payout Potential (Shares)  
Name and Title   RSU
Target Values
as of
Grant Date
    Number
of RSUs
Granted
    PSU
Target Values
as of
Grant Date
    At Threshold
Performance
(50% of
Target)
    At Target
Performance
    At
Maximum
Performance
(200% of
Target)
 
Bryan H. Sayler
Chief Executive Officer & President
  $ 1,207,485       5,083     $ 2,817,465       5,931       11,861       23,722  
Christopher L. Tucker
Senior Vice President
& Chief Financial Officer
  $ 345,000       1,452     $ 805,000       1,695       3,389       6,778  
David M. Schatz
Senior Vice President,
General Counsel & Secretary
  $ 210,000       884     $ 490,000       1,032       2,063       4,126  

  

Item 7.01Regulation FD Disclosure

 

Today, November 19, 2026, the Company is issuing a press release (attached as Exhibit 99.1) announcing its financial and operating results for the fourth quarter and fiscal year ended September 30, 2026. The Company will conduct a related Webcast conference call today at 4:00 p.m. Central Time. The press release will be posted on the Company’s web site located at http://www.escotechnologies.com. It can be viewed through the “Investor News” page of the web site under the “Investor Center” tab, although the Company reserves the right to discontinue that availability at any time.

 

Item 9.01Financial Statements and Exhibits

 

(d)Exhibits

 

 Exhibit No.Description of Exhibit
99.1Press Release issued November 19, 2026
104Cover Page Inline Interactive Data File

 

Other Matters

 

The information in this report furnished pursuant to Item 2.02 and Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 as amended (“Exchange Act”) or otherwise subject to the liabilities of that section, unless the Company incorporates it by reference into a filing under the Securities Act of 1933 as amended or the Exchange Act.

 

Any references to the Company’s web site address included in this Form 8-K and the press release are intended only as inactive textual references and not as active links to its web site. Information contained on the Company’s web site does not constitute part of this Form 8-K or the press release.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 19, 2026

 

  ESCO TECHNOLOGIES INC.
   
  By: /s/David M. Schatz
    David M. Schatz
    Senior Vice President, General Counsel and Secretary

 

 

 

 

Exhibit 99.1

 

NEWS FROM

 

 

For more information contact:

Kate Lowrey - VP of Investor Relations

(314) 213-7277 / klowrey@escotechnologies.com

 

ESCO REPORTS FOURTH QUARTER AND FISCAL 2026 RESULTS

 

- Q4 Sales increase 9% to $384 Million -

- Q4 Entered Orders increase 22% to $392 Million -

- Q4 GAAP EPS from Continuing Operations increases 14% to $1.97 -

- Q4 Adjusted EPS from Continuing Operations increases 15% to $2.67 -

 

- FY 2026 Sales increase 21% to $1.3 Billion -

- FY 2026 Entered Orders increase 11% to $1.7 Billion -

- FY 2026 GAAP EPS from Continuing Operations increases 25% to $5.63 -

- FY 2026 Adjusted EPS from Continuing Operations increases 40% to $8.42 -

 

ST. LOUIS, November 19, 2026 – ESCO Technologies Inc. (NYSE: ESE) (ESCO, or the Company) today reported its operating results for the fourth quarter and fiscal year ended September 30, 2026 (Q4 2026 and FY 2026, respectively).

 

Operating Highlights

 

·Q4 2026 Sales increased $31 million (9 percent) to $384 million compared to $353 million in Q4 2025. All sales growth in Q4 2026 was organic, as the acquisition of ESCO Maritime Solutions (Maritime) was completed in Q3 2025.
   
·FY 2026 Sales increased $227 million (21 percent) to $1.3 billion compared to $1.1 billion in FY 2025. Organic sales increased $106 million (10 percent) and the Maritime acquisition added $121 million (11 percent) of inorganic revenue growth for the full year.
   
·Q4 2026 GAAP EPS from Continuing Operations increased 14 percent to $1.97 per share compared to $1.73 per share in Q4 2025. Q4 2026 Adjusted EPS from Continuing Operations increased 15 percent to $2.67 per share compared to $2.32 per share in Q4 2025.
   
·FY 2026 GAAP EPS from Continuing Operations increased 25 percent to $5.63 per share compared to $4.49 per share in FY 2025. FY 2026 Adjusted EPS from Continuing Operations increased 40 percent to $8.42 per share compared to $6.03 per share in FY 2025.
   
·Q4 2026 Entered Orders increased $71 million (22 percent) to $392 million (book-to-bill of 1.02x).
   
·FY 2026 Entered Orders increased $172 million (11 percent) to $1.7 billion (book-to-bill of 1.31x), resulting in record year-end backlog of $1.5 billion. Organic orders increased $232 million (20 percent).
   
·Net Cash provided by Operating Activities from Continuing Operations was $102 million in Q4 2026 and $296 million for FY 2026 (an increase of $95 million compared to FY 2025).

 

 

 

 

Bryan Sayler, Chief Executive Officer and President, commented, “ESCO closed fiscal 2026 with strong performance. 2026 has been a very exciting year for ESCO and our financial results have resulted in record orders, sales, adjusted earnings and operating cash flow.

 

“Our employees’ hard work, expertise, and teamwork drove operational improvements and made this year’s achievements possible, building a strong foundation for continued success. Looking ahead, the addition of Megger, our record backlog, and strong positions in markets with durable long-term growth drivers reinforce our confidence in ESCO’s future.”

 

Segment Performance

 

Aerospace & Defense (A&D)

 

·Q4 2026 sales increased $19.8 million (12 percent) to $190.2 million from $170.4 million in Q4 2025. Sales growth in the quarter was driven by strength in Navy and commercial aerospace. FY 2026 sales increased $174.3 million (36 percent) to $652.5 million from $478.2 million in FY 2025. Organic sales increased $53.2 million (12 percent) and Maritime added $121.1 million of inorganic revenue growth for the year. Sales growth for the year was driven by strength in Navy and commercial and military aerospace.
   
·Q4 2026 EBIT increased $9.5 million to $56.4 million from $46.9 million in Q4 2025. Adjusted EBIT increased $7.7 million in Q4 2026 to $56.4 million (29.7 percent margin) from $48.7 million (28.6 percent margin) in Q4 2025. FY 2026 EBIT increased $62.6 million to $187.7 million from $125.1 million in FY 2025. FY 2026 Adjusted EBIT increased $58.4 million to $188.1 million (28.8 percent margin) from $129.7 million (27.1 percent margin) in FY 2025. The increase in Adjusted EBIT was driven by leverage on higher volume and price increases, partially offset by mix and inflationary pressures for both the quarter and the year.
   
·Q4 2026 entered orders increased $51.7 million (36 percent) to $193.6 million (book-to-bill of 1.02). Orders strength in the quarter was driven by strong Navy and military aerospace. FY 2026 entered orders increased $59.8 million (7 percent) to $955.4 million (book-to-bill of 1.46), resulting in record year-end backlog of $1.1 billion. Organic orders increased $119.4 million (24.8 percent). Orders strength in the year was driven by strong Navy, commercial aerospace and military aerospace.

 

Utility Solutions Group (USG)

 

·Q4 2026 sales increased $3.8 million (3 percent) to $114.0 million from $110.2 million in Q4 2025. Doble sales increased by $7.2 million (8 percent) and NRG sales decreased by $3.4 million (20 percent). Sales growth in the quarter was primarily driven by higher condition monitoring and services revenue at Doble, partially offset by lower renewables revenue at NRG. FY 2026 sales increased $15.0 million (4 percent) to $395.0 million from $380.0 million in FY 2025. Doble sales increased $32.7 million (10 percent) and NRG sales decreased $17.7 million (27 percent) for the year. Sales growth for the year was driven by broad strength across all product lines at Doble, partially offset by lower renewables revenue at NRG.

 

 

 

 

·Q4 2026 EBIT decreased $0.7 million to $31.2 million from $31.9 million in Q4 2025. Adjusted EBIT decreased $0.6 million in Q4 2026 to $31.4 million (27.5 percent margin) from $32.0 million (29.1 percent margin) in Q4 2025. The decrease in Adjusted EBIT in the quarter was driven by deleverage on lower volume at NRG, inflationary pressures, and mix, partially offset by price increases and leverage on higher volume at Doble. FY 2026 EBIT increased $0.5 million to $95.2 million from $94.7 million in FY 2025. FY 2026 Adjusted EBIT increased $1.1 million to $96.3 million (24.4 percent margin) from $95.2 million (25.0 percent margin) in FY 2025. The increase in Adjusted EBIT for the year was driven by leverage on higher volume at Doble and price increases, partially offset by deleverage on lower volume at NRG and inflationary pressures.
   
·Q4 2026 entered orders increased $11.8 million (10 percent) to $128.0 million (book-to-bill of 1.12). Doble orders increased $11.6 million (11 percent) to $112.9 million and NRG orders increased $0.2 million (1 percent) to $15.1 million compared to Q4 2025. FY 2026 entered orders increased $51.4 million (13 percent) to $454.9 million (book-to-bill of 1.15) resulting in year-end backlog of $203.4 million. Doble orders increased $64.3 million (19 percent) and NRG orders decreased $12.9 million (20 percent) for the year. For both the quarter and the year, orders were driven by broad strength across Doble’s product lines as electric utilities invested in grid maintenance and expansion, partially offset by lower renewables related to the expiration of U.S. tax credits.
   
·As previously disclosed, the Megger transaction closed on October 1, 2026. Integration planning began during the regulatory approval process, and execution of those plans and cost reduction initiatives is now under way.

 

RF Test & Measurement (Test)

 

·Q4 2026 sales increased $7.7 million (11 percent) to $79.8 million from $72.1 million in Q4 2025. FY 2026 sales increased $37.3 million (16 percent) to $274.5 million from $237.2 million in FY 2025. Sales growth in both the quarter and the year was primarily driven by military and automotive projects, filters for U.S. government data centers and secure facilities, and industrial and medical shielding.
   
·Q4 2026 EBIT increased $0.6 million to $13.2 million from $12.6 million in Q4 2025. Q4 2026 Adjusted EBIT increased $1.3 million to $13.9 million (17.5 percent margin) from $12.6 million (17.5 percent margin) in Q4 2025. FY 2026 EBIT increased $6.8 million to $40.9 million from $34.1 million in FY 2025. FY 2026 Adjusted EBIT increased $9.1 million to $43.7 million (15.9 percent margin) from $34.6 million (14.6 percent margin) in FY 2025. The increase in Adjusted EBIT for both the quarter and the year was driven by leverage on higher volume and price increases, partially offset by inflationary pressures.
   
·Q4 2026 entered orders increased $7.9 million (13 percent) to $70.7 million. Orders strength in the quarter was driven by a large automotive order and several military projects, partially offset by lower wireless and medical shielding. FY 2026 entered orders increased $61.2 million (23 percent) to a record $326.9 million (book-to-bill of 1.19) resulting in record year-end backlog of $239.6 million. Orders strength for the year was driven by military and automotive projects, filters for U.S. government data centers and secure facilities, and industrial shielding.

 

 

 

 

Business Outlook – FY 2027

 

Expectations for growth in FY 2027 compared to FY 2026:

 

·Net sales are expected to grow 55 to 58 percent to a range of $2.05 to $2.09 billion on a consolidated basis, with A&D growing 7 to 9 percent, USG growing 170 to 175 percent (7 to 9 percent organic growth plus Megger revenue of $640 to $660 million), and Test growing 5 to 7 percent.
   
·Adjusted EBIT is expected to increase approximately 51 to 55 percent with Adjusted EBIT margins of 21.2 to 21.8 percent of sales.
   
·Adjusted EBITDA is expected to increase approximately 53 to 57 percent with Adjusted EBITDA margins of 24.2 to 24.8 percent of sales.
   
·Interest is expected to be in the range of $61 to $63 million in FY 2027.
   
·The effective income tax rate is expected to be approximately 22.5 percent in FY 2027.
   
·FY 2027 Adjusted EPS is expected to increase 12 to 15 percent to a range of $9.40 to $9.70 per share.
   
·Q1 2027 Adjusted EPS is expected to increase 13 to 19 percent compared to Q1 2026 and be in the range of $1.85 - $1.95 per share.
   
·Consistent with prior years, revenues and Adjusted EPS are expected to grow sequentially throughout the year.

 

Dividend Payment

 

The next quarterly cash dividend of $0.08 per share will be paid on January 19, 2027 to stockholders of record on January 4, 2027.

 

2027 Annual Meeting

 

The 2027 Annual Meeting of the Company’s shareholders will be held on January 29, 2027.

 

Conference Call

 

The Company will host a conference call today, November 19, at 4:00 p.m. Central Time, to discuss the Company’s Q4 2026 results. A live audio webcast and an accompanying slide presentation will be available in the Investor Center of ESCO’s website. Participants may also access the webcast using this registration link. For those unable to participate, a webcast replay will be available after the call in the Investor Center of ESCO’s website.

 

 

 

 

VACCO Divestiture

 

During Q4 2025, the Company completed the sale of VACCO Industries. The VACCO operating results are presented as Discontinued Operations in the attached tables and are excluded from the discussion of the Company’s results from Continuing Operations for the comparable periods.

 

Forward-Looking Statements

 

Statements in this press release regarding Management’s intentions, expectations and guidance for fiscal 2027, including restructuring and cost reduction actions, sales, orders, revenues, margin, earnings, Adjusted EPS, acquisition related amortization, and any other statements which are not strictly historical, are “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. securities laws.

 

Investors are cautioned that such statements are only predictions and speak only as of the date of this release, and the Company undertakes no duty to update them except as may be required by applicable laws or regulations. The Company’s actual results in the future may differ materially from those projected in the forward-looking statements due to risks and uncertainties that exist in the Company’s operations and business environment including but not limited to those described in Item 1A, “Risk Factors”, of the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2025 and the following: the impacts of climate change and related regulation of greenhouse gases; the impacts of labor disputes, civil disorder, wars, including the conflicts involving Iran and Lebanon, elections, political changes, tariffs and trade disputes, terrorist activities, cyberattacks or natural disasters on the Company’s operations and those of the Company’s customers and suppliers; disruptions in manufacturing or delivery arrangements due to shortages or unavailability of materials or components; restrictions or closures of critical supply routes such as the Strait of Hormuz; other supply chain disruptions; inability to access work sites; the timing and content of future contract awards or customer orders; the timely appropriation, allocation and availability of Government funds; the termination for convenience of Government and other customer contracts or orders; weakening of economic conditions in served markets; the success of the Company’s competitors; changes in customer demands or customer insolvencies; competition; intellectual property rights; technical difficulties or data breaches; the availability of acquisitions; delivery delays or defaults by customers; performance issues with key customers, suppliers and subcontractors; material changes in the costs and availability of certain raw materials; material changes in the cost of credit; changes in laws and regulations including but not limited to changes in accounting standards and taxation; changes in interest, inflation and employment rates; costs relating to environmental matters arising from current or former facilities; uncertainty regarding the ultimate resolution of current disputes, claims, litigation or arbitration; and the integration and performance of acquired businesses.

 

 

 

 

Non-GAAP Financial Measures

 

The financial measures EBIT, Adjusted EBIT, EBITDA, Adjusted EBITDA, and Adjusted EPS are presented in this press release. The Company defines “EBIT” as earnings before interest and taxes, “EBITDA” as earnings before interest, taxes, depreciation and amortization, “Adjusted EBIT” and “Adjusted EBITDA” as excluding the net impact of the items described in the attached Reconciliation of Non-GAAP Financial Measures, and “Adjusted EPS” as GAAP earnings per share excluding the net impact of the items described and reconciled in the attached Reconciliation of Non-GAAP Financial Measures.

 

EBIT, Adjusted EBIT, EBITDA, Adjusted EBITDA, and Adjusted EPS are not recognized in accordance with U.S. generally accepted accounting principles (GAAP). However, Management believes EBIT, Adjusted EBIT, EBITDA, and Adjusted EBITDA are useful in assessing the operational profitability of the Company’s business segments because they exclude interest, taxes, depreciation, and amortization, which are generally accounted for across the entire Company on a consolidated basis. EBIT is also one of the measures used by Management in determining resource allocations within the Company as well as incentive compensation. The presentation of EBIT, Adjusted EBIT, EBITDA, Adjusted EBITDA, and Adjusted EPS provides important supplemental information to investors by facilitating comparisons with other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results. The use of non-GAAP financial measures is not intended to replace any measures of performance determined in accordance with GAAP.

 

About ESCO

 

ESCO Technologies is a global provider of highly engineered products and solutions serving diverse end-markets. It manufactures filtration and fluid control products, advanced composites, as well as signature and power management solutions for aviation, Navy, and industrial customers. ESCO is an industry leader in designing and manufacturing RF test and measurement products and systems; and provides diagnostic instruments, software and services to industrial power users and the electric utility and renewable energy industries. Headquartered in St. Louis, Missouri, ESCO and its subsidiaries have offices and manufacturing facilities worldwide. For more information on ESCO and its subsidiaries, visit ESCO’s website at www.escotechnologies.com.

 

 

 

 

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Operations (Unaudited)

 (Dollars in thousands, except per share amounts)  

 

   Three Months
Ended
September 30, 2026
   Three Months
Ended
September 30, 2025
 
Net Sales  $383,994    352,674 
Cost and Expenses:          
Cost of sales   226,596    203,235 
Selling, general and administrative expenses   64,945    63,333 
Amortization of intangible assets   20,286    20,582 
Interest expense   3,103    5,129 
Other expenses (income), net   1,271    828 
Total costs and expenses   316,201    293,107 
           
Earnings before income taxes   67,793    59,567 
Income tax expense   16,574    14,713 
           
Earnings from continuing operations   51,219    44,854 
           
Earnings from discontinued operations, net of tax expense of $458   -    1,156 
(Loss) gain on sale of discontinued operations, net of tax benefit / expense of $871 and $54,000, respectively   (129)   172,642 
Net (loss) earnings from discontinued operations   (129)   173,798 
           
Net earnings  $51,090    218,652 
           
Diluted - GAAP          
Continuing operations  $1.97    1.73 
Discontinued operations   (0.00)   6.70 
Net earnings  $1.97    8.43 
           
Diluted - As Adjusted Basis          
Continuing Operations  $2.67(1)   2.32(2)
           
Diluted average common shares O/S:   25,985    25,928 

 

(1) Q4 2026 Adjusted EPS from continuing operations excludes $0.70 per share of after-tax charges consisting of: $0.18 of debt financing and acquisition costs at Corporate related to the Megger acquisition and $0.52 of acquisition related amortization.
   
(2) Q4 2025 Adjusted EPS from continuing operations excludes $0.59 per share of after-tax charges consisting of: $0.05 of Maritime inventory step-up charges, $0.01 of restructuring charges (primarily severance) within the USG segment, and $0.53 of acquisition related amortization.

 

 

 

 

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Operations (Unaudited)

(Dollars in thousands, except per share amounts)  

 

   Year Ended
September 30, 2026
   Year Ended
September 30, 2025
 
Net Sales  $1,322,021    1,095,388 
Cost and Expenses:          
Cost of sales   771,870    634,303 
Selling, general and administrative expenses   259,984    234,638 
Amortization of intangible assets   81,372    53,317 
Interest expense   17,095    17,502 
Other expenses (income), net   3,611    2,775 
Total costs and expenses   1,133,932    942,535 
           
Earnings before income taxes   188,089    152,853 
Income tax expense   41,888    36,554 
           
Earnings from continuing operations   146,201    116,299 
           
Earnings from discontinued operations, net of tax expense of $3,464   -    10,282 
Gain on sale of discontinued operations, net of tax benefit / expense of $508 and $54,000, respectively   1,048    172,642 
Net earnings from discontinued operations   1,048    182,924 
           
Net earnings  $147,249    299,223 
           
Diluted - GAAP          
Continuing operations  $5.63    4.49 
Discontinued operations   0.04    7.06 
Net earnings  $5.67    11.55 
           
Diluted - As Adjusted Basis          
Continuing Operations  $8.42(1)   6.03(2)
           
Diluted average common shares O/S:   25,965    25,910 

 

(1) FY 2026 Adjusted EPS from continuing operations excludes $2.79 per share of after-tax charges consisting primarily of $0.09 of restructuring charges within Test, USG & A&D segments, $0.61 of debt financing and acquisition costs at Corporate related to the Megger acquisition, and $2.09 of acquisition related amortization.
   
(2) FY 2025 Adjusted EPS from continuing operations excludes $1.54 per share of after-tax charges consisting of: $0.15 of Corporate acquisition costs, $0.14 of Maritime inventory step-up charges and stamp duties, $0.02 of restructuring charges within the Test and USG segments, and $1.23 of acquisition related amortization.

 

 

 

 

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES

Condensed Business Segment Information (Unaudited) - Continuing Operations basis

(Dollars in thousands)

 

   GAAP   As Adjusted 
   Q4 2026   Q4 2025   Q4 2026   Q4 2025 
Net  Sales                    
Aerospace & Defense  $190,168    170,373    190,168    170,373 
USG   114,019    110,211    114,019    110,211 
Test   79,807    72,090    79,807    72,090 
Totals  $383,994    352,674    383,994    352,674 
                     
EBIT                    
Aerospace & Defense  $56,364    46,893    56,405    48,660 
USG   31,245    31,933    31,410    32,019 
Test   13,176    12,588    13,927    12,588 
Corporate   (29,889)   (26,718)   (9,319)   (8,852)
Consolidated EBIT   70,896    64,696    92,423    84,415 
Less: Interest expense   (3,103)   (5,129)   (1,095)   (5,129)
Less: Income tax expense   (16,574)   (14,713)   (21,987)   (19,248)
Net earnings  $51,219    44,854    69,341    60,038 

 

Note 1: Adjusted net earnings of $69.3 million in Q4 2026 exclude $18.1 million (or $0.70 per share) of after-tax charges consisting of: $0.18 of debt financing and acquisition costs at Corporate related to the Megger acquisition and $0.52 of acquisition related amortization.

 

Note 2: Adjusted net earnings of $60.0 million in Q4 2025 exclude $15.2 million (or $0.59 per share) of after-tax charges consisting of: $0.05 of Maritime inventory step-up charges, $0.01 of restructuring charges (primarily severance) within the USG segment, and $0.53 of acquisition related amortization.

 

EBITDA Reconciliation to Net earnings:

 

           Q4 2026 -   Q4 2025 - 
   Q4 2026   Q4 2025   As Adj   As Adj 
Consolidated EBITDA  $97,467    91,316    101,368    93,328 
Less: Depr & Amort   (26,571)   (26,620)   (8,945)   (8,913)
Consolidated EBIT   70,896    64,696    92,423    84,415 
Less: Interest expense   (3,103)   (5,129)   (1,095)   (5,129)
Less: Income tax expense   (16,574)   (14,713)   (21,987)   (19,248)
Net earnings  $51,219    44,854    69,341    60,038 

 

 

 

 

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES

Condensed Business Segment Information (Unaudited) - Continuing Operations basis

(Dollars in thousands)

 

   GAAP   As Adjusted 
   FY 26   FY 25   FY 26   FY 25 
Net  Sales                    
Aerospace & Defense  $652,509    478,192    652,509    478,192 
USG   394,995    379,995    394,995    379,995 
Test   274,517    237,201    274,517    237,201 
Totals  $1,322,021    1,095,388    1,322,021    1,095,388 
                     
EBIT                    
Aerospace & Defense  $187,736    125,139    188,055    129,676 
USG   95,243    94,741    96,339    95,159 
Test   40,873    34,111    43,681    34,576 
Corporate   (118,668)   (83,636)   (37,641)   (36,994)
Consolidated EBIT   205,184    170,355    290,434    222,417 
Less: Interest expense   (17,095)   (17,502)   (8,224)   (17,502)
Less: Income tax   (41,888)   (36,554)   (63,534)   (48,527)
Net earnings  $146,201    116,299    218,676    156,388 

 

Note 1: Adjusted net earnings of $218.7 million in FY 2026 exclude $72.5 million (or $2.79 per share) of after-tax charges consisting of: $0.09 of restructuring charges within Test, USG & A&D segments, $0.61 of debt financing and acquisition costs at Corporate related to the Megger acquisition and $2.09 of acquisition related amortization.

 

Note 2: Adjusted net earnings of $156.4 million in FY 2025 exclude $40.1 million (or $1.54 per share) of after-tax charges consisting of: $0.15 of Corporate acquisition costs, $0.14 of Maritime inventory step-up charges and stamp duties, $0.02 of restructuring charges within the Test and USG segments, and $1.23 of acquisition related amortization.

 

EBITDA Reconciliation to Net earnings:

 

          FY 26 -   FY 25 - 
   FY 26   FY 25   As Adj   As Adj 
Consolidated EBITDA  $311,828    245,376    326,550    256,303 
Less: Depr & Amort   (106,644)   (75,021)   (36,116)   (33,886)
Consolidated EBIT   205,184    170,355    290,434    222,417 
Less: Interest expense   (17,095)   (17,502)   (8,224)   (17,502)
Less: Income tax expense   (41,888)   (36,554)   (63,534)   (48,527)
Net earnings  $146,201    116,299    218,676    156,388 

 

 

 

 

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets (Unaudited)

(Dollars in thousands)

 

   September 30, 2026   September 30, 2025 
Assets          
Cash and cash equivalents  $93,294    101,350 
Accounts receivable, net   262,032    253,554 
Contract assets   143,788    90,730 
Inventories   228,564    217,807 
Other current assets   36,554    25,065 
Total current assets   764,232    688,506 
Property, plant and equipment, net   178,204    172,493 
Intangible assets, net   649,701    723,973 
Goodwill   762,403    761,931 
Operating lease assets   45,416    47,707 
Other assets   20,592    15,778 
   $2,420,548    2,410,388 
           
Liabilities and Shareholders' Equity          
Current maturities of long-term debt  $0    20,000 
Accounts payable   120,118    96,534 
Contract liabilities   295,789    216,590 
Current income tax payable   6,511    62,007 
Other current liabilities   127,231    113,017 
Total current liabilities   549,649    508,148 
Deferred tax liabilities   105,860    112,390 
Non-current operating lease liabilities   42,392    44,403 
Other liabilities   31,611    38,576 
Long-term debt   14,000    166,000 
Shareholders' equity   1,677,036    1,540,871 
   $2,420,548    2,410,388 

 

 

 

 

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows (Unaudited)

(Dollars in thousands)

 

   Year Ended
September 30, 2026
   Year Ended
September 30, 2025
 
Cash flows from operating activities:          
Net earnings  $147,249    299,223 
(Earnings) loss from discontinued operations   (1,048)   (182,924)
Adjustments to reconcile net earnings to net cash          
provided by operating activities:          
Depreciation and amortization   106,644    75,021 
Stock compensation expense   14,333    10,671 
Changes in assets and liabilities   35,391    9,381 
Effect of deferred taxes   (6,149)   (10,976)
Other   (825)   - 
Net cash provided by operating activities - continuing operations   295,595    200,396 
Net cash (used) provided by operating activities - discontinued operations   (58,918)   41,543 
Net cash provided by operating activities   236,677    241,939 
           
Cash flows from investing activities:          
Acquisition of business, net of cash acquired   (10,232)   (472,006)
Capital expenditures   (34,096)   (36,322)
Additions to capitalized software and other   (11,055)   (15,844)
Other   3,248    - 
Net cash used by investing activities - continuing operations   (52,135)   (524,172)
Net cash provided by investing activities - discontinued operations   1,540    268,383 
Net cash used by investing activities   (50,595)   (255,789)
           
Cash flows from financing activities:          
Proceeds from long-term debt   149,000    661,000 
Principal payments on long-term debt and short-term borrowings   (321,000)   (597,000)
Dividends paid   (8,290)   (8,262)
Debt issuance costs   (1,456)   - 
Other   (10,725)   (6,197)
Net cash (used) provided by financing activities - continuing operations   (192,471)   49,541 
Net cash used by financing activities - discontinued operations   -    - 
Net cash (used) provided by financing activities   (192,471)   49,541 
           
Effect of exchange rate changes on cash and cash equivalents   (1,667)   (304)
           
Net (decrease) increase in cash and cash equivalents   (8,056)   35,387 
Cash and cash equivalents, beginning of period   101,350    65,963 
Cash and cash equivalents, end of period  $93,294    101,350 

 

 

 

 

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES

Other Selected Financial Data (Unaudited)

(Dollars in thousands)

  

Backlog And Entered Orders - Q4 2026  A&D   USG   Test   Total 
Beginning Backlog - 7/1/26  $1,102,446    189,426    248,643    1,540,515 
Entered Orders   193,605    127,970    70,720    392,295 
Sales   (190,168)   (114,019)   (79,807)   (383,994)
Ending Backlog - 9/30/26  $1,105,883    203,377    239,556    1,548,816 

 

Backlog And Entered Orders - FY 2026   A&D    USG    Test    Total 
Beginning Backlog - 10/1/25  $803,002    143,460    187,175    1,133,637 
Entered Orders   955,390    454,912    326,898    1,737,200 
Sales   (652,509)   (394,995)   (274,517)   (1,322,021)
Ending Backlog - 9/30/26  $1,105,883    203,377    239,556    1,548,816 

 

 

 

 

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES

Reconciliation of Non-GAAP Financial Measures (Unaudited)

 

EPS – Adjusted Basis Reconciliation – Q4 2026    
EPS Continuing Operations– GAAP Basis – Q4 2026  $1.97 
Adjustments (defined below)   0.70 
EPS Continuing Operations– As Adjusted Basis – Q4 2026  $2.67 

 

Adjustments of $0.70 per share consisting primarily of: $0.18 of debt financing and acquisition costs at Corporate related to the Megger acquisition and $0.52 of acquisition related amortization.

 

EPS – Adjusted Basis Reconciliation – Q4 2025    
EPS Continuing Operations– GAAP Basis – Q4 2025  $1.73 
Adjustments (defined below)   0.59 
EPS Continuing Operations– As Adjusted Basis – Q4 2025  $2.32 

 

Adjustments of $0.59 per share consisting primarily of: $0.05 of Maritime inventory step-up charges, $0.01 of restructuring charges with the USG segment and $0.53 of acquisition related amortization.

 

EPS – Adjusted Basis Reconciliation – FY 2026    
EPS Continuing Operations– GAAP Basis – FY 2026  $5.63 
Adjustments (defined below)   2.79 
EPS Continuing Operations – As Adjusted Basis – FY 2026  $8.42 

 

Adjustments of $2.79 per share consisting primarily of: $0.09 of restructuring charges within Test, USG and A&D segments, $0.61 of debt financing and acquisition costs related to the Megger acquisition, and $2.09 of acquisition related amortization.

 

EPS – Adjusted Basis Reconciliation – FY 2025    
EPS Continuing Operations– GAAP Basis – FY 2025  $4.49 
Adjustments (defined below)   1.54 
EPS Continuing Operations – As Adjusted Basis – FY 2025  $6.03 

 

Adjustments of $1.54 per share consisting primarily of: $0.15 of Corporate acquisition costs, $0.14 of Maritime inventory step-up charges and stamp duties, $0.02 of restructuring charges within the Test and USG segments, and $1.23 of acquisition related amortization.

 

 

 

Filing Exhibits & Attachments

4 documents

Keep reading